在过去的24年里,周围的恶性瘤:一个书法计量和高度计量研究
Furkan Ozer1, Ahmet Ufuk Kılıçtaş2, Bilgeşah Kılıçtaş3
1Department of Ophthalmology, Nevşehir State Hospital, Nevşehir, Türkiye.
European journal of ophthalmology
|October 15, 2025
概括
这项研究映射了全球关于周期性癌症的研究:基底细胞癌 (BCC),状细胞癌 (SCC) 和脂质腺癌 (SGC). BCC是最受研究的,而脂质腺癌 (SGC) 研究是有限的,这表明需要合作.
科学领域:
- 眼科医生 眼科 眼科
- 皮肤病学 皮肤病学
- 病理学 病理学 病理学
背景情况:
- 周围的恶性瘤,包括基底细胞癌 (BCC),状细胞癌 (SCC) 和脂质腺癌 (SGC),代表了重大的临床挑战.
- 了解全球研究格局对于确定趋势和改进领域至关重要.
研究的目的:
- 从2000年到2024年分析BCC,SCC和SGC的全球研究成果和影响.
- 确定出版趋势,主要贡献者,地理分布以及研究对这些周期性恶性瘤的影响.
主要方法:
- 从科学网络核心集合中对558篇文章进行了图书统计分析.
- VOSviewer 用于对关键词,合著和引用进行网络分析.
- 在Altmetric注意力得分 (AAS),引用数量和出版物特征之间的相关性分析.
主要成果:
- 基底细胞癌 (BCC) 主导着出版物,在2020年达到顶峰. 状细胞癌 (SCC) 呈现逐渐增加,而脂质腺癌 (SGC) 仍然不足.
- 美国在BCC和SCC研究方面处于领先地位,而印度在SGC研究方面占据着重要地位. 眼科是主要的学科,由皮肤学和病理学支持.
- 阿尔特度注意力得分 (AAS) 与出版年龄有负相关,但与期刊指标有正相关.
结论:
- 脂质腺癌 (SGC) 的研究量较低可能源于其罕见性和诊断挑战.
- 学术和高度影响的变化突出了加强合作和沟通的机会,以提高周期性瘤的科学可见性和临床理解.
相关概念视频
02:20Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
01:18Survival Curves
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...